Open access peer-reviewed chapter

Coordination of DNA Base Excision Repair by Protein-Protein Interactions

By Nina Moor and Olga Lavrik

Submitted: September 5th 2018Reviewed: November 21st 2018Published: December 17th 2018

DOI: 10.5772/intechopen.82642

Downloaded: 618


The system of base excision repair (BER) evolved to correct the most abundant DNA damages in mammalian cells is the most essential for maintaining the genome integrity. The multistep BER process involves several enzymes and protein factors functioning in a coordinated fashion that ensures the repair efficiency. The coordination is facilitated by the formation of protein complexes stabilized via either direct or indirect DNA-mediated interactions. This review focuses on direct interactions of proteins participating in BER with each other and with noncanonical factors found recently to modulate the efficiency of BER. All the known partners of main BER participants, the sites responsible for their interaction, and the characteristics of protein-protein affinity are summarized. Well-documented evidences of how DNA intermediates and posttranslational modifications of proteins modulate protein-protein interactions are presented. The available data allow to suggest that the multiprotein complexes are assembled with the involvement of a scaffold protein XRCC1 and poly(ADP-ribose) polymerase 1, a key regulator of the BER process, irrespective of the DNA damage; the composition and the structure of the complexes are dynamically changed depending on the DNA damage, its chromatin environment, and the step of BER process.


  • base excision repair
  • protein-protein interactions
  • noncanonical factors
  • posttranslational modifications of proteins
  • coordination of DNA repair

1. Introduction

Many forms of DNA damage are generated due to permanent action of endogenous and exogenous factors. In order to maintain genome integrity, cells have evolved several specific pathways to repair DNA lesions. Base excision repair (BER), which ensures correction of the most abundant damages—modified nitrogenous bases and apurinic/apyrimidinic (AP) sites—is critically important for survival of human cells [1, 2, 3]. Enzyme and protein factors of BER also participate in the repair of DNA single-strand breaks (SSBs) considered as a separate pathway of the BER system [4, 5]. The other repair systems (Figure 1) deal with bulky nucleobase lesions (NER), DNA double-strand breaks (HR; NHEJ), and mismatched bases (MMR). Impaired DNA repair is associated with embryonic lethality, rapid aging, and a variety of severe human hereditary diseases as well as development of cancer [7, 8]. The balance of DNA damage and DNA repair is highly relevant to both cancerogenesis and effective anti-cancer therapy due to the ability of cancer cells to repair therapeutically induced DNA damage and impact therapeutic efficacy [9]. Hence, intensive investigation of DNA damage repair is essential to advance our understanding of molecular mechanisms maintaining genome integrity and to develop cancer therapy.

Figure 1.

DNA damages generated by endogenous and exogenous factors and specific systems of their repair. Letter X in DNA duplex marks mismatched base pair. Reproduced with modification from [6] with permission of Pleiades Publishing, Ltd.


2. Main steps of BER and proteins involved

The widely accepted model for mammalian BER involves several sub-pathways presented schematically in Figure 2. The damaged bases are removed by DNA glycosylases specific to the certain type of damage; mono- and bifunctional DNA glycosylases form an intact or cleaved (via β- or β/δ-elimination mechanism) AP site, respectively [10]. The intact AP site is further processed by the main enzymatic activity of multifunctional AP endonuclease 1 (APE1) producing the one-nucleotide gap with 3′-hydroxyl and 5′-deoxyribose phosphate residue (5′-dRp) at the gap margins. Terminal blocking groups in the DNA intermediates produced by bifunctional DNA glycosylases are removed by the phosphatase activity of polynucleotide kinase/phosphatase (PNKP) or 3′-phosphodiesterase and 3′-phosphatase activities of APE1. At the next step, a bifunctional DNA polymerase β (Polβ) catalyzes the removal of the 5′-dRp residue by its dRp-lyase activity and one-nucleotide gap filling by the nucleotidyl transferase activity. The repair of DNA chain integrity via joining of the single-strand break is completed by DNA ligase IIIα (LigIIIα) acting in the complex with X-ray repair cross-complementing protein 1 (XRCC1). This main BER sub-pathway is known as a short-patch repair (SP BER). When the 5′-dRp residue is modified, it cannot be removed by the Polβ-lyase activity, and a long-patch sub-pathway of BER (LP BER) is realized. Polβ initiates the DNA strand displacement synthesis continued by replicative DNA polymerases δ and ε (Polδ and Polε) acting in the complexes with protein factors PCNA and RFC. The flap structure produced at this step is removed by the flap endonuclease 1 (FEN1). According to another model, FEN1 is capable of sequential removing nucleotides at the 5′-end of the break, and the produced gap is filled by the activities of Polβ or Polλ [11, 12]. Final ligation of the break is catalyzed by DNA ligase I (LigI). A new long-patch sub-pathway of BER that involves formation of a 9-nucleotide gap 5′ to the lesion has been recently discovered; it is mediated by DNA helicase RECQ1 and ERCC1-XPF endonuclease in cooperation with PARP1 and replication protein A (RPA) [13].

Figure 2.

BER sub-pathways for repair of damaged bases and DNA SSBs. Catalytic steps and proteins involved are schematically presented. The terminal groups in DNA intermediates and SSBs are designated as follows: PUA, 3′-phospho-α,β-unsaturated aldehyde; p, 3′−/5′-phosphate; OH, 3′−/5′-hydroxyl; dRP, 5′-deoxyribose phosphate; PG, 3′-phosphoglycolate; Ade, 5′-aldehyde group; and AMP, 5′-AMP. Reproduced with modification from [6] with permission of Pleiades Publishing, Ltd.

Repair of DNA SSBs arising directly via disintegration of the oxidized sugar and as a result of erroneous activity of DNA topoisomerase 1 involves the following steps: (1) detection of the break, (2) removal of blocking groups, (3) filling the gap, and (4) ligation of the break (Figure 2). The DNA breaks are detected primarily by poly(ADP-ribose) polymerase 1 (PARP1); the unblocking of 3′- and 5′-ends in breaks is catalyzed by specific activities of APE1, PNKP, aprataxin (APTX), and tyrosyl-DNA phosphodiesterase 1 (TDP1); gap filling and ligation are catalyzed by the same set of enzymes that participate in the respective steps of the short-patch repair of the damaged DNA bases (Polβ and LigIIIα). PARP1 is activated via the interaction with the damaged DNA; it catalyzes the synthesis of poly(ADP-ribose) (PAR) and covalent attachment of the PAR polymer to PARP1 itself and other proteins involved in the DNA repair [4, 5]. The XRCC1 protein is considered to be a main target of PARP1 catalyzed poly(ADP-ribosyl)ation. PARP1 has been suggested to play the main role in recruitment of the XRCC1 protein to the damages of chromosomal DNA [4, 5]. XRCC1 displays no enzymatic activity and is proposed to function as a scaffold protein of the BER process. PARP2 is another enzyme from the PARP family that is activated via binding with DNA SSB and catalyzes PAR synthesis [14, 15]. The importance of both PARP1 and PARP2 for DNA repair is indicated by knockout studies revealed that knocking out the parp1gene activity increased the sensitivity of cells to DNA-damaging agents, while parp1and parp2double knockouts caused early embryonic lethality [16]. The role of PARP2 in BER processes and its possible synergism with PARP1 action are under intensive investigation [17, 18]. Poly(ADP-ribosyl)ation of proteins is a transient modification that turns over rapidly due to the enzymatic activity of poly(ADP-ribose) glycohydrolase (PARG) [19]. Another important function of PARP1 in DNA repair is remodeling of chromatin structure via poly(ADP-ribosyl)ation of histones and binding of the remodeling proteins with the synthesized PAR polymer [20].

Coordinated action of the enzymes catalyzing the sequential individual reactions of the multistep BER process is required for efficient repair of damaged DNA. One of the coordination mechanisms proposed previously is the “passing the baton,” that implies the transfer of the DNA intermediate from the enzyme remaining bound to the product to the next enzyme [1, 21]. This model is supported by numerous data on mutual modulation of activities of the BER enzymes [2, 21]. The stimulating effect of APE1 on the catalytic activity of DNA glycosylase OGG1 explored in detail recently does not require direct interaction between the proteins and is adequately described by the “passing the baton” model [22]. Another mechanism of coordination implies the formation of multiprotein complexes (so-called repairosomes) composed of enzymes and scaffold proteins [2]. XRCC1 is a striking example of the scaffold protein involved in BER. The existence of “repairosomes” is evidenced by multiple interactions between enzymes and protein factors of BER detected even independent of the DNA damage. Most likely both mechanisms are relevant to coordination of the BER process.

3. Proteins involved in BER interact directly with each other

Many protein participants of BER have been shown to interact physically with each other. Data on their direct interactions and structural domains involved are summarized in Table 1. Interactions of the XRCC1 protein with multiple partners have been explored in the greatest detail. The structure of XRCC1 is composed of three domains linked with disordered fragments (linkers XL1 and XL2), one of which (XL1) contains a nuclear localization signal (Figure 3) [23]. The availability of two BRCT domains (BRCTa and BRCTb) mediating protein-protein interactions (for review, see [24]), in addition to the N-terminal domain (NTD) involved in DNA binding, favors the main function of XRCC1 as scaffold in structural organization of “repairosomes”. Interestingly, the binding sites of four enzymes catalyzing sequential steps of BER—APE1, PNKP (N-terminal domain), Polβ, and LigIIIα—are localized in different structural modules of XRCC1 (Figure 3). A second PNKP interaction site localized recently in XRCC1 (linker XL1) binds PNKP (catalytic domain) with lower affinity; this interaction has been proposed to stimulate PNKP activity, in contrast to the high-affinity interaction responsible for PNKP recruitment to DNA damage [25]. At the same time, the binding sites of various DNA glycosylases in XRCC1 overlap with those for APE1, Polβ, and PARP1 (Figure 3). It is likely that the enzymes initiating the repair of damaged bases form dynamic contacts with XRCC1 and other constituents of “repairosome.” Direct interactions of DNA glycosylases NEIL1, NEIL2, and MYH with other enzymes of SP and LP BER (APE1, PNKP, Polβ, LigIIIα, Polδ, FEN1, and LigI) have been shown (Table 1). The multiprotein complexes of XRCC1 detected in many studies to be formed by recombinant proteins and cell extracts contain Polβ, PNKP, and LigIIIα as stable partners, and their presence enhances the interaction of XRCC1 with DNA glycosylases [30, 31, 33, 52]. PNKP and LigIIIα are the constituents of another multiprotein complex containing XRCC1 and TDP1 [53].

Figure 3.

The multidomain structure of XRCC1 and specific regions responsible for its scaffold function in BER. Protein partners and their binding sites in XRCC1 are shown schematically in the upper part of the figure. At the top, 3D structure models determined for the N-terminal domain, a fragment of XL2 linker, and the BRCTb domain crystallized as complexes with the respective domains of Polβ, PNKP, and LigIIIα (PDB codes: 3K75, 2W3O, and 3QVG) are presented. Reproduced with modification from [6] with permission of Pleiades Publishing, Ltd.

Protein (domain)aProtein partner (domain)a,b
XRCC1 (NTD)Polβ (CD) [23, 26, 27, 28]
XRCC1 (NTD + XL1)NTH1 (CTD); NEIL1 (CTD); NEIL2 (NTD) [29, 30, 31]
XRCC1 (XL1)PCNA [32]; UNG2 (CD) [33]; PNKP (CD) [25]
XRCC1 (XL1 + BRCTa)APE1, OGG1 [34]
XRCC1 (BRCTa)MPG, NTH1 (CTD), NEIL1 (CTD), NEIL2 (NTD) [29, 30, 31]; PARP1 (DBD, BRCT), PARP2 (WGR) [35, 36]
XRCC1 (XL2)PNKP (NTD), APTX (FHA) [23, 37, 38, 39]
XRCC1 (BRCTb)LigIIIα (BRCT) [40, 41, 42]
XRCC1TDP1 [43]
PARP1 (DBD + BRCT)Polβ (CD), PARP1, PARP2 (WGR) [36, 44, 45]; LigIIIα (55–122) [46]
PARP1 (CD)TDP1 (NTD) [47]
APE1 (CTD)MYH (293–351) [48]
NEIL1 (CTD)PNKP, Polβ, FEN1, LigI [49]
Polβ (NTD)NEIL1 (CTD), NEIL2 (NTD) [30, 31]; LigI (NTD) [50]
Polβ (CD)PARP2 (WGR) [36]
PolβAPE1 [51]; PNKP [52]
LigIIIα (BRCT)NEIL1 (CTD), NEIL2 (NTD) [30, 31]; PARP2 (WGR) [36]; PNKP [52]; TDP1 (NTD) [53, 54]

Table 1.

Interactions between main proteins involved in BER.

Protein domain(s) responsible for the interaction with protein partner(s) is shown in brackets. Structural composition of multidomain proteins:XRCC1: NTD 1–155, XL1 156–309, BRCTa 310–405, XL2 406–528, BRCTb 529–633; [23]PARP1: ZnF1 1–96, ZnF2 97–206, NLS 207–240, ZnF3 241–366, BRCT 381–484, WGR 518–661, CD 662–1014; [55]PARP2: NTD 1–63, WGR 64–198, CD 199–559; [36]LigIIIα: ZnF 1–100, linker 101–170, DBD 171–390, CD 391–836, BRCT 837–922 [56]. Designations: NTD/CTD, N-/C-terminal domain; CD, catalytic domain; DBD, DNA-binding domain; XL1/XL2, linker 1/2 in XRCC1 protein; NLS, nuclear localization signal; ZnF, zinc finger; FHA, forkhead-associated domain. The data for human and mouse (PARP2) recombinant proteins are presented.

Techniques used in studies: affinity coprecipitation [25, 26, 29, 30, 31, 32, 33, 34, 35, 36, 40, 41, 44, 45, 46, 47, 48, 49, 50], two-hybrid analysis [27, 30, 31, 35, 37, 46, 51, 52, 53, 54], gel filtration [27, 28, 41, 42], ultracentrifugation [27, 50], coimmunoprecipitation [29, 31, 32, 33, 36, 37, 38, 39, 41, 43, 46, 47, 52, 53, 54], fluorescence titration [38], fluorescence polarization [39], surface plasmon resonance [41], small-angle X-ray scattering [42], X-ray crystallography [23, 42, 45], and NMR [48].

The PARP1 protein consists of multiple structural modules constituting an N-terminal DNA-binding domain and a C-terminal catalytic domain in addition to the central BRCT domain [55, 57]. The coordinating function of PARP1 in BER can be realized via direct interaction with some enzymes (PNKP, Polβ, LigIIIα, and TDP1) or indirect interaction mediated by the XRCC1 protein. The binding sites for main BER enzymes (Polβ and LigIIIα) and the scaffold XRCC1 protein are localized in the DNA binding and BRCT domains, while that for TDP1 is completed by the catalytic domain of PARP1 (Table 1). As a consequence, TDP1 is capable of the formation of a stable ternary complex with PARP1 and XRCC1 [53]. The overlapped binding sites for the majority of PARP1 partners create prerequisites for dynamic contacts in the preformed multiprotein assemblies, which can be stabilized in the complex with automodified PARP1 (PAR-PARP1). Many BER participants such as XRCC1, Polβ, PNKP, APTX, TDP1, LigIIIα, and LigI contain PAR-binding motifs, and some of them (XRCC1, LigIIIα, and TDP1) have been shown to interact with PAR-PARP1 more efficiently than with the unmodified PARP1 [46, 47, 58, 59]. The poly(ADP-ribose) acceptors have been identified in all the structural domains of PARP1; this expands significantly the platform for the formation of the “repairosomes” [60]. In contrast to PARP1, PARP2 does not have the BRCT domain and specialized zinc-fingers for DNA binding [15, 61]. The nonconserved WGR domain of PARP2 is responsible for the interaction with proteins (Table 1) as well as for DNA break detection [15]. The function of PARP2 (similar to that of PARP1) in coordination of the DNA repair process can be further mediated through its interaction with XRCC1 [17].

Direct interactions between the enzymes catalyzing different, usually sequential, steps of the BER process have been demonstrated in several studies (Table 1). Interestingly, the enzyme of the final step of SP BER—LigIIIα has direct binding partners among the enzymes involved in both the initial and middle steps of the process (NEIL1, NEIL2, PNKP, and TDP1), utilizing the BRCT domain for the interaction. Data reported recently indicate the ability of this enzyme to control the assembly of multiprotein complexes on single-strand DNA damages similar to PARP1, thus suggesting a scaffolding function of LigIIIα in the coordination of BER [62].

Most interactions between proteins involved in BER have been detected using the affinity coprecipitation, two-hybrid analysis, and immunoprecipitation techniques (Table 1). These techniques provide no information on physicochemical, structural, and conformational parameters of the complexes, leaving open many questions on the mechanisms of their functioning, such as the relative contribution of the proteins to the formation of macromolecular associates and their stoichiometry, the roles of dynamic interactions, conformational changes, and DNA intermediates in the formation of functional assemblies. Information on the structural organization of these complexes is very limited. The 3D structures determined by X-ray crystallography are known for the isolated domains/fragments of the XRCC1 protein in complexes with the respective domains of its stable partners Polβ, LigIIIα, and PNKP (Figure 3). It is interesting to note that the specific contact region of the XRCC1 protein with LigIIIα (not involved in XRCC1 homodimerization)—a polypeptide consisting of hydrophobic amino acid residues at the N-terminus of the BRCTb domain—was revealed in the X-ray study [42]. The binding sites localized in proteins by the traditional nonequilibrium techniques participate obviously in the most stable interactions. The available structural data are not sufficient to decipher the molecular mechanisms of BER coordination.

Using quantitative equilibrium techniques—fluorescence titration and fluorescence (Förster) resonance energy transfer (FRET)—we have characterized several homo- and hetero-oligomeric complexes of various BER proteins (Figure 4). N-hydroxysuccinimide esters of 5(6)-carboxyfluorescein (FAM) and 5(6)-carboxytetramethylrhodamine (TMR) were used for N-terminal fluorescent labeling of proteins. Direct (not mediated by DNA or other proteins) interactions of APE1 with Polβ, TDP1, and PARP1 and of Polβ with TDP1 as well as homo-oligomerization of APE1 have been detected for the first time. The apparent equilibrium dissociation constant (Kd) of the complexes is in the range of 23 to 270 nM. The XRCC1-PNKP complex characterized previously by using a similar approach has a Kd value in the same range [64]. The highest stability of the XRCC1 complex with Polβ was confirmed by the nonequilibrium approach, size exclusion chromatography coupled with multi-angle laser light-scattering (SEC-MALLS) [63]. Model DNAs imitating various DNA intermediates of BER have been shown to modulate the structure of protein complexes and their stability to different extents, depending on the type of DNA damage [63]. The DNA-dependent effects on the protein affinity for each other were most pronounced for the complexes of APE1 with different proteins (Polβ, XRCC1, and PARP1). Our findings advance understanding of the mechanisms underlying coordination and regulation of the BER process. The dependence of the efficiency of APE1 interaction with Polβ on the type of DNA intermediate indicates that functions of the two key enzymes are coordinated not only due to the differences in their affinity for DNAs as proposed previously in [65] but also due to the strength of their interaction with each other, which is controlled by DNA at different steps of repair. The higher affinity of APE1 for Polβ in the presence of AP-site containing DNA than in the complex with the incision product suggests that the efficient repair is facilitated by the transfer of the DNA intermediate to Polβ immediately during the incision step. The higher affinity of APE1 and Polβ for PARP1 than for each other in the presence of SSB containing DNA suggests that the regulation of functions of the BER participants via DNA-dependent modulation of their affinity for each other represents a common mechanism for various proteins. On the contrary, the stability of the XRCC1-Polβ complex does not depend on the presence of DNA intermediates, even though the most pronounced effect of different DNAs on the FRET signal, which reflects structural rearrangement of the complex, was detected for this complex. Our data indicate that this complex revealed in [66] to protect each protein from proteasome-mediated degradation may also serve as a stable component of the multiprotein assemblies, similar to the XRCC1-LigIIIα complex. Moreover, the XRCC1 binding sites with Polβ and LigIIIα do not overlap with regions mediating interactions with most other protein partners, thus enabling participation of the preformed ternary Polβ-XRCC1-LigIIIα complex in the entire Polβ- and XRCC1-dependent BER sub-pathway. Formation of the stable ternary complex in vivois evidenced by synchronous accumulation of XRCC1, Polβ, and LigIIIα at the damage sites of DNA [67, 68].

Figure 4.

Direct interactions between BER proteins detected by fluorescence titration and FRET [63]. The EC50 values represent apparent equilibrium dissociation constants of the complexes (determined as half-maximal effective concentrations of protein partners); the length of black arrows connecting the protein pairs is proportional to the binding affinity; the underlined EC50 values have changed remarkably in the presence of DNA intermediates. The interaction in each pair of FAM- (donor) and TMR-labeled (acceptor) proteins is characterized by FRET efficiency (E); the highest change of the E value induced by DNA intermediates (increase/decrease with +/− sign) is presented in brackets. Reproduced with modification from [6] with permission of Pleiades Publishing, Ltd.

Recently, the oligomeric states of BER proteins and their complexes have been estimated based on hydrodynamic sizes determined by using dynamic light scattering (DLS) technique [69]. All the proteins have been proposed to form homodimers upon their self-association. The most probable oligomerization state of the binary complexes formed by PARP1 with various proteins is a heterotetramer. The oligomerization state of the binary complexes formed by XRCC1 varies from heterodimer to heterotetramer, depending on the partner.

Interaction of PARP1 with Polβ and APE1 detected in our study [63] in both the absence and presence of DNA may contribute to regulation of the BER process. Cooperation between PARP1 and BER enzymes at different steps of DNA repair is evident from our previous studies. Interaction of PARP1, Polβ, and APE1 with the “central” DNA intermediate in BER established by photoaffinity labeling of BER proteins in the cell extract suggests interplay between these proteins during repair synthesis catalyzed by Polβ [70]. The ability of PARP1 to compete with APE1 for the binding of an AP-site containing DNA indicates possible cooperation between the proteins upon the recognition and further incision of the AP site [71]. Following the incision of AP site, PARP1 can catalyze the synthesis of poly(ADP-ribose). According to the initially proposed mechanism of its action, PARP1 dissociates from the complex with DNA after covalent attachment of the negatively charged PAR polymer. Further studies of an active role of PAR in the formation of the repair complexes have modified this hypothesis. It was established that following poly(ADP-ribosyl)ation, PARP1 was capable of covalent binding to the photoreactive DNA intermediate; the lifetime of such complexes was shown to depend on both the size of covalently bound PAR and the initial affinity of PARP1 for the DNA damage [70]. Complexes of PAR-PARP1 with damaged DNA have been detected by atomic force microscopy [72]. Recently, kinetics of poly(ADP-ribosyl)ation and PAR homeostasis (but not the PARP1 protein) have been proposed to play a primary role in protection of cells from acute DNA damage [73]. Hence, the formation of BER complexes on the damaged DNA can be regulated via either poly(ADP-ribosyl)ation of proteins or their interactions with PAR polymer synthesized by PARP1 and PARP2. Poly(ADP-ribose) is the most important cell regulator of protein-protein and protein-nucleic acid interactions. [20, 74, 75, 76, 77, 78].

4. Interactions of BER proteins with noncanonical factors contribute to the regulation of DNA repair

Many proteins with various cellular functions, not considered previously to be involved in BER, have been shown to regulate this process via interactions with main participants. The HMGB1 protein—a chromatin architecture factor—interacts directly with three BER enzymes (APE1, Polβ, and FEN1), modulates their catalytic activity in the process of DNA repair, and, hence, ensures regulation of the process via the SP or LP BER sub-pathway [79, 80, 81]. Human DNA-binding proteins hSSB1 and SATB1 form complexes with DNA glycosylase OGG1, thus enhancing its efficiency in recognition of DNA damage and its repair [82, 83]. The human mitochondrial single-stranded DNA binding protein (mtSSB) interacts with NEIL1 in the presence and absence of a DNA substrate revealed to modulate the oligomerization state and stability of the NEIL1-mtSSB complex [84]. Protein factors of unknown nature that are not involved in chromatin structure remodeling form complex with DNA glycosylase NTH1 and stimulate its activity in BER initiation [85]. The SSRP1 protein entailed in chromatin disassembly as a histone H2A/H2B chaperone interacts with both PAR-PARP1 and XRCC1 and facilitates repair of SSBs [86]. In general, the mechanisms of BER functioning within chromatin are largely unexplored (for example, see [87]), remaining possibility to discover new noncanonical factors of BER.

In addition to multiple enzymatic functions in DNA repair, APE1 is known to play a regulatory role in the transcription processes, RNA processing, and ribosome biogenesis [76, 88]. The activities of the multifunctional enzyme, its expression level, and intracellular localization are regulated by its interaction with the multifunctional protein nucleophosmin (NPM1) [89]. Direct interactions of APE1 and several DNA glycosylases (TDG, NEIL2, NTH1, OGG1, and UNG2) with protein factors of nucleotide excision repair (XPC, XPG, CSB, and RPA) and homologous recombination (Rad52) have been shown to play a regulatory role in the overlapping repair pathways [90].

PARP1 forms stable complexes with Ku70/Ku80 proteins, and this interaction has been proposed to be an important regulator of the Ku70/80 heterodimer function in the repair of DNA double-strand breaks (DSBs) [91, 92]. Recent studies have demonstrated the involvement of Ku70 and Ku80 proteins in different steps of BER [93]. Septin4, a member of GTP binding protein family considered to be an essential component of the cytoskeleton, is a novel PARP1 interacting protein, and the interaction is enhanced under oxidative stress [94]. PARP1 interacts with NR1D1 protein, a nuclear receptor subfamily 1 group D member 1; the interaction is enhanced under oxidative stress and inhibits the catalytic activity of PARP1 [95]. Whether the interaction of these noncanonical factors with PARP1 may contribute to regulation of BER remains to be explored. The protein DBC1 (deleted in breast cancer 1), one of the most abundant yet enigmatic proteins in mammals containing a conserved domain similar to Nudix hydrolases (hydrolyzing nucleoside diphosphates) but lacking catalytic activity, interacts directly with the BRCT domain of PARP1; the strength of the interaction shown to inhibit the catalytic activity of PARP1 is modulated by NAD+ concentration [96]. Thus, a novel function of NAD+ to directly regulate protein-protein interactions, the modulation of which may protect against cancer, radiation, and aging, has been discovered.

The multifunctional Y-box-binding protein 1 (YB-1) is another noncanonical factor of BER. The proteolytic fragment of this positively charged intrinsically disordered protein localized in the nucleus is formed in response to DNA damage [97]. We have shown that YB-1 interacts with poly(ADP-ribose) and could be an acceptor for PARP1/PARP2 catalyzed poly(ADP-ribosyl)ation in vitro[98]. Several proteins essential for BER—APE1, Polβ, NEIL1, PARP1, and PARP2—directly interact with YB-1, although most complexes being less stable than the complexes of BER proteins with each other (the apparent Kd values are in the range of 340 to 810 nM as compared to those presented in Figure 4) [99]. A strong interaction detected between APE1 and YB-1 could be an important factor for the cooperative action of these multifunctional proteins in transcription regulation [100]. Interactions of YB-1 protein with BER enzymes could be responsible for the regulation of their activities: the AP-endonuclease activity of APE1 and 5′-dRp-lyase activity of Polβ are inhibited in the presence of YB-1, while the AP-lyase activity of NEIL1 is stimulated [99]. YB-1 was found to stimulate the catalytic activity of PARP1 via strong binding with poly(ADP-ribose) linked to PARP1, which increased the lifetime of this complex in DNA [99]. Acting as a cofactor of PARP1, YB-1 decreases the efficiency of PARP1 inhibitors [101].

5. Intersection of posttranslational modifications and protein-protein interactions in BER coordination

Posttranslational modifications (PTMs) of proteins involved in BER modulate catalytic and DNA-binding activities of individual proteins, their expression, intracellular localization, structure, and stability as well as protein-protein interactions and may therefore contribute to regulation of DNA repair either directly or indirectly. Numerous studies of PTMs and their functions in BER have been reviewed previously [90, 102, 103, 104, 105, 106]. As mentioned above, PARP1 modifies itself and binding partners with poly(ADP-ribose). Among the targets of PARP1 catalyzed ADP-ribosylation are two key BER proteins—XRCC1 and Polβ, and XRCC1 negatively regulates PARP1 activity [35, 107]. The automodification of PARP1 has been shown to enhance its interaction with XRCC1, LigIIIα, and TDP1; the length of PAR polymer determines the efficiency of PAR-mediated accumulation of XRCC1 on DNA damage [46, 47, 108]. Recent studies have identified other PTMs, such as phosphorylation, acetylation, and methylation, to regulate the activity of PARP1 [104, 106]. Phosphorylation of PARP1 mediated by protein kinase CDK2 represents a novel DNA-independent mechanism of PARP1 activation [106]. Modifications of PARP1 mediated by AMP-activated protein kinase (AMPK) and lysine acetyltransferase 2B (PCAF) modulate both the activity of PARP1 and ADP-ribosylation of other proteins [106]. Polyubiquitination of PARP1 by E3 ubiquitin protein ligase is promoted by the automodification of PARP1 and targets PAR-PARP1 for proteasomal degradation [106]. It has to be noted that nonproteolytic roles of protein ubiquitination in regulation of DSBs repair and NER have been demonstrated [105]. PARP1 modification (at Lys486 residue) with small ubiquitin-like protein catalyzed by SUMO E3 ligase (SUMOylation) enhances p300-dependent acetylation of PARP1, while it has no effect on its activity [106].

The most abundant evidence on PTM-mediated regulation of protein-protein interactions is available for the XRCC1 protein. XRCC1 is an extensively phosphorylated protein with more than 45 phosphorylation sites localized in the linker regions and BRCTa domain [109]. Catalyzed by p38 MAPK kinase phosphorylation of the BRCTa domain (at T358 and T367 residues) has been shown to regulate PAR-mediated recruitment of XRCC1 to DNA damage [109]. The phosphorylation of XRCC1 by checkpoint kinase 2 (CHK2) at Thr284 residue in vivoand in vitroincreases the affinity of XRCC1 for DNA glycosylase MPG, facilitating thereby initiation of BER [110]. As shown recently, the same kinase interacts with PARP1 and modifies the BRCT domain; the CHK2-dependent phosphorylation of PARP1 stimulates its catalytic activity and interaction with XRCC1 [111]. Seven sites of XRCC1 phosphorylation mediated by kinase CK2 (localized in the XL2 linker) are necessary to modulate the interaction of XRCC1 with end-processing enzymes—PNKP, APTX, and PNK-like factor APLF—and the efficiency of repair of chromosomal DNA SSBs [37, 38, 39, 112, 113]. Notably, the phosphorylated and unmodified forms of XRCC1 bind different structural domains of PNKP and modulate the kinase activity of PNKP or its accumulation on DNA damage, respectively [37, 38]. The oxidized form of XRCC1 stabilized by a disulfide bridge between Cys12 and Cys20 residues forms a more stable (in comparison with the reduced form) complex with Polβ; an increase in the number of intermolecular contacts in this complex has been confirmed by X-ray analysis of the complex [23]. The existence of oxidized form of XRCC1 in vivois essential to protect cells against extreme oxidative stress [114]. XRCC1 is a substrate for SUMOylation promoted by DNA damage-induced PARylation; SUMOylation of XRCC1 contributes to regulation of BER via increasing its binding affinity for Polβ [115].

The most frequent PTMs discovered for the multifunctional protein APE1 include phosphorylation, acetylation, S-nitrosylation, S-glutathionylation, formation of disulfide bonds, and ubiquitination [90, 102]. Most modifications modulate redox activity of APE1 and its regulatory function in transcription. As Cys residues are targets of different modifications, it is essential to understand the competition between these PTMs and their roles in APE1 function. Numerous studies on APE1 phosphorylation by a variety of protein kinases provide contradictory data on modulation of the repair activity of APE1 [102]. Recently, it has been shown that acetylation of APE1 (at Lys residues in the mammalian-conserved N-terminal extension) enhances both the AP-endonuclease activity and the interaction with XRCC1 and XRCC1-LigIIIα complex, ensuring cell survival in response to genotoxic stress [116].

Acetylation of DNA glycosylase TDG weakens its interaction with APE1 and produces opposite effects on the excision activity of the enzyme toward various types of base damages; repair of damage induced by the chemotherapeutic action of 5-fluorouracil is enhanced by the TDG acetylation [90]. Based on these data, the acetylation status of TDG within tumor cells was proposed to impact the chemotherapy efficacy. Phosphorylation of the flexible N-terminus of DNA glycosylase UNG2 (at Thr6 or Tyr8 residues) shown to disrupt interaction with the PCNA factor, without affecting the UNG2 catalytic activity or its RPA interaction, has been proposed to regulate the formation of the ternary PCNA-UNG2-RPA protein complex [117].

Various PTMs of Polβ (acetylation, phosphorylation, and methylation) modulate its 5′-dRp-lyase and nucleotidyl transferase activities; the only example of PTMs impacts on protein-protein interaction is inhibition of Polβ-PCNA interaction due to PRMT1-dependent methylation of Arg137 [102]. The enzymes completing BER—LigIIIα and LigI—undergo posttranslational modification in vitroand in vivo; however, the intersection of their PTMs with protein-protein interactions is yet unknown [102].


6. Conclusions

Intensive studies of DNA repair system ensuring repair of damaged bases and single-strand DNA breaks (BER) in recent decades have made impressive progress in establishing the participants of the repair process, main sub-pathways, and auxiliary mechanisms activated when the main BER sub-pathways are inefficient. In addition to the enzymes responsible for catalytic steps of BER, several proteins, such as XRCC1, PARP1, PARP2, and others, have been identified as BER participants essential for assembling and functioning of the dynamic multiprotein system. Multiprotein complexes of various compositions can be formed without the involvement of DNA, but their structure and stability are modulated by the damaged DNA and intermediates formed in different steps of BER. Interactions of individual BER enzymes with DNA substrates and products have been deciphered in detail by X-ray studies. This method is of little use to explore dynamic supramolecular structures operating in DNA repair. The next step is required to clarify how the BER system functions upon association of the multiprotein complexes with chromatin; novel methods in structural analysis, such as electron microscopy, and more complex models imitating DNA repair in chromatin structure might be helpful to apply. How protein-protein interactions and posttranslational modifications coordinate BER with other DNA repair systems requires future studies. Elucidation of molecular mechanisms underlying efficient BER and its dysregulation in pathological states will help broaden our understanding the origins of diseases and provide novel strategy of their treatment.


This work was financially supported partially under Russian State funded budget project (VI.57.1.2, 0309-2016-0001) and by the Russian Science Foundation (grant No. 14-24-00038).

Conflict of interest

The authors declare that there is no conflict of interest.

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Nina Moor and Olga Lavrik (December 17th 2018). Coordination of DNA Base Excision Repair by Protein-Protein Interactions, DNA Repair- An Update, Maddalena Mognato, IntechOpen, DOI: 10.5772/intechopen.82642. Available from:

chapter statistics

618total chapter downloads

4Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Mitochondrial Genome Maintenance: Damage and Repair Pathways

By Ulises Omar García-Lepe and Rosa Ma Bermúdez-Cruz

Related Book

First chapter

Modelling DNA Methylation Dynamics

By Karthika Raghavan and Heather J. Ruskin

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us